Cardiotoxicity after the lymphoma

dc.authoridMerdan Fayda / 0000-0002-2800-5327en_US
dc.authorscopusidMerdan Fayda / 6506348846en_US
dc.authorwosidMerdan Fayda / AAF-7370-2019
dc.contributor.authorÖzen, Alaattin
dc.contributor.authorFayda, Merdan
dc.date.accessioned2022-06-16T12:21:00Z
dc.date.available2022-06-16T12:21:00Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractSUMMARY Radiotherapy (RT) is the cornerstone component of the current successful treatment of Hodgkin lymphoma (HL). Although RT has been used alone to cure in most patients in decades, combined modality regimes are preferred in most HL patients currently, besides early-stage lymphocyte predominance HL and for selected patients with classical HL who have contraindications to chemotherapy. Although clas-sic RT fields, doses, and techniques have fundamentally changed over the years, the heart is still an organ at risk, and patients with radiation-induced cardiovascular complications are increased in the long term. In this paper, we aimed to review literature about radiation-induced cardiotoxicity in lymphoma patients treated with mediastinal RT. © 2022.en_US
dc.identifier.citationÖzen, A., & Fayda, M. (2022). Cardiotoxicity after the lymphoma. Turk Onkoloji Dergisi, 37(2), 44-50. doi:10.5505/tjo.2022.S1007en_US
dc.identifier.doi10.5505/tjo.2022.S1007en_US
dc.identifier.endpage50en_US
dc.identifier.issn1300-7467en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85127663439en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage44en_US
dc.identifier.urihttps://doi.org/10.5505/tjo.2022.S1007
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2914
dc.identifier.volume37en_US
dc.identifier.wosWOS:001132582400007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorFayda, Merdan
dc.language.isoenen_US
dc.publisherIstanbul Tip Fakultesien_US
dc.relation.ispartofIstanbul Tip Fakultesien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCardiotoxicityen_US
dc.subjectHodgkin Lymphoma (HL)en_US
dc.subjectRadiotherapyen_US
dc.titleCardiotoxicity after the lymphomaen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
pdf_TOD_1324.pdf
Boyut:
663.72 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: